Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

Work With Your Doctor to Get Signifor / Signifor LAR (pasireotide) Approved by Blue Cross Blue Shield in Texas: Provider Collaboration Guide

Answer Box: Getting Signifor LAR Approved by Blue Cross Blue Shield in Texas Signifor LAR (pasireotide) requires prior authorization from Blue Cross Blue Shield of Texas, with strict medical necessity criteria. Success depends on strong collaboration between you and your endocrinologist to document failed first-generation treatments and provide comprehensive biochemical

Resources to Get Palynziq (pegvaliase-pqpz) Approved by Blue Cross Blue Shield in Pennsylvania: Complete Forms, Portals & Appeals Guide

Answer Box: Getting Palynziq Covered by Blue Cross Blue Shield in Pennsylvania Fastest Path to Approval: Palynziq requires prior authorization from all Pennsylvania Blue Cross Blue Shield plans (Highmark, Independence Blue Cross). You'll need documented PKU diagnosis, blood phenylalanine >600 µmol/L, and failed sapropterin trial. Submit

How to Get Palynziq (pegvaliase-pqpz) Covered by Blue Cross Blue Shield in Virginia: Complete Guide with ICD-10, HCPCS Codes, and Appeal Forms

Answer Box: Getting Palynziq Covered in Virginia Blue Cross Blue Shield Virginia (Anthem) covers Palynziq for adults with PKU when blood phenylalanine levels remain ≥600 µmol/L despite dietary management. Prior authorization is required with strict criteria: age 18+, failed dietary therapy (±sapropterin), specialist involvement, and REMS enrollment. Fastest path

How to Get Sylvant (Siltuximab) Covered by Blue Cross Blue Shield in Ohio: Coding, Appeals, and State Review Process

Answer Box: Getting Sylvant Covered in Ohio Blue Cross Blue Shield Ohio requires prior authorization for Sylvant (siltuximab) as of May 2024. The fastest path to approval involves three key steps: 1) Submit proper coding (ICD-10 D47.Z2 for Castleman disease, HCPCS J2860 for billing), 2) Document HIV-negative and HHV-8-negative

How to Get Keytruda (pembrolizumab) Covered by Blue Cross Blue Shield Georgia: Prior Authorization, Appeals & Alternatives Guide

Quick Answer: Getting Keytruda Covered by Blue Cross Blue Shield Georgia Keytruda requires prior authorization from Blue Cross Blue Shield Georgia with specific biomarker testing (PD-L1 or MSI-H/dMMR) and documentation of diagnosis, staging, and prior treatments. If denied, you have 60 days to file an external review with the

Getting Orfadin (Nitisinone) Covered by Blue Cross Blue Shield in Georgia: Complete Coding, Prior Authorization, and Appeals Guide

Answer Box: Getting Orfadin Covered by Blue Cross Blue Shield in Georgia Blue Cross Blue Shield Georgia requires prior authorization for Orfadin (nitisinone) with specific coding and documentation. Use ICD-10 code E70.2 for hereditary tyrosinemia type 1, bill with HCPCS J8499, and submit biochemical proof (elevated succinylacetone) plus genetic

How to Get Hetlioz (Tasimelteon) Covered by Blue Cross Blue Shield in Ohio: Prior Authorization Forms, Appeals, and Coding Guide

Quick Answer: Getting Hetlioz Covered by Blue Cross Blue Shield in Ohio Hetlioz (tasimelteon) requires prior authorization from Blue Cross Blue Shield in Ohio. The fastest path to approval involves: 1) Submit a complete PA form with specialist documentation for Non-24 Sleep-Wake Disorder (ICD-10: G47.24) or Smith-Magenis Syndrome (Q93.

How Long Does It Take to Get Tavalisse (Fostamatinib) Approved by Blue Cross Blue Shield in Georgia? Timeline & Appeals Guide

Answer Box: Getting Tavalisse Approved in Georgia Standard approval timeline: 2-5 business days for Blue Cross Blue Shield Georgia prior authorization requests. Expedited reviews: 24 hours for urgent cases. Tavalisse requires documentation of chronic immune thrombocytopenia (ITP) diagnosis and insufficient response to prior therapies (steroids, IVIG, TPO receptor agonists). If

Complete Guide to Getting Kanuma (Sebelipase Alfa) Covered by Blue Cross Blue Shield in Florida: ICD-10, J-Codes, and Appeals Process

Answer Box: Getting Kanuma Covered by Florida Blue Blue Cross Blue Shield of Florida (Florida Blue) requires prior authorization for Kanuma (sebelipase alfa) with strict diagnostic and clinical criteria. The fastest path to approval involves three key steps: (1) Confirm LAL-D diagnosis with genetic testing or enzyme assay documentation, (2)

How to Get Rezlidhia (olutasidenib) Covered by Blue Cross Blue Shield of Texas: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Rezlidhia Covered by BCBS Texas Blue Cross Blue Shield of Texas covers Rezlidhia (olutasidenib) for relapsed/refractory AML with IDH1 mutation, but requires prior authorization with specific documentation. To get approval: 1) Gather IDH1 mutation test results and prior therapy records, 2) Submit PA request with medical